These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11931622)

  • 1. Synthesis of photoreactive phosphatidic acid analogues displaying activatory properties on cyclic AMP-phosphodiesterases. Photoaffinity labeling of an isoform of phosphodiesterase.
    Picq M; Huang Y; Lagarde M; Doutheau A; Nemoz G
    J Med Chem; 2002 Apr; 45(8):1678-85. PubMed ID: 11931622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
    Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
    J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of PDE-4 cAMP phosphodiesterases by phosphatidic acid.
    Grange M; Picq M; Prigent AF; Lagarde M; Nemoz G
    Cell Biochem Biophys; 1998; 29(1-2):1-17. PubMed ID: 9631235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases.
    Richter W; Conti M
    J Biol Chem; 2004 Jul; 279(29):30338-48. PubMed ID: 15131123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cAMP-phosphodiesterases by phosphatidic acid binding.
    Grange M; Sette C; Prigent AF; Lagarde M; Némoz G
    Lipids; 1999; 34 Suppl():S83. PubMed ID: 10419099
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of a cyclic nucleotide phosphodiesterase 4 (PDE4) from rat thymocytes by phosphatidic acid.
    Savany A; Abriat C; Némoz G; Lagarde M; Prigent AF
    Cell Signal; 1996 Nov; 8(7):511-6. PubMed ID: 9023016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid.
    Baillie GS; Huston E; Scotland G; Hodgkin M; Gall I; Peden AH; MacKenzie C; Houslay ES; Currie R; Pettitt TR; Walmsley AR; Wakelam MJ; Warwicker J; Houslay MD
    J Biol Chem; 2002 Aug; 277(31):28298-309. PubMed ID: 11994273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hunting the emesis and efficacy targets of PDE4 inhibitors: identification of the photoaffinity probe 8-(3-azidophenyl)-6- [(4-iodo-1H-1-imidazolyl)methyl]quinoline (APIIMQ).
    Macdonald D; Perrier H; Liu S; Laliberté F; Rasori R; Robichaud A; Masson P; Huang Z
    J Med Chem; 2000 Oct; 43(21):3820-3. PubMed ID: 11052785
    [No Abstract]   [Full Text] [Related]  

  • 9. Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+.
    Huston E; Gall I; Houslay TM; Houslay MD
    J Cell Sci; 2006 Sep; 119(Pt 18):3799-810. PubMed ID: 16940352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
    Ang KL; Antoni FA
    J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between phosphatidic acid and cyclic nucleotide phosphodiesterases in activated human blood mononuclear cells.
    Zakaroff-Girard A; El Bawab S; Némoz G; Lagarde M; Prigent AF
    J Leukoc Biol; 1999 Mar; 65(3):381-90. PubMed ID: 10080543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis.
    Huai Q; Colicelli J; Ke H
    Biochemistry; 2003 Nov; 42(45):13220-6. PubMed ID: 14609333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
    Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
    Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes.
    El Bawab S; Macovschi O; Sette C; Conti M; Lagarde M; Nemoz G; Prigent AF
    Eur J Biochem; 1997 Aug; 247(3):1151-7. PubMed ID: 9288942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A; Jerez MJ; Gil C; Martinez A
    Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP
    J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.
    Liu S; Laliberté F; Bobechko B; Bartlett A; Lario P; Gorseth E; Van Hamme J; Gresser MJ; Huang Z
    Biochemistry; 2001 Aug; 40(34):10179-86. PubMed ID: 11513595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid.
    Némoz G; Sette C; Conti M
    Mol Pharmacol; 1997 Feb; 51(2):242-9. PubMed ID: 9203629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.